These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6753888)

  • 1. Absorption and antidysrhythmic activity of oral disopyramide phosphate after acute myocardial infarction.
    Kumana CR; Rambihar VS; Willis K; Gupta RN; Tanser PH; Cairns JA; Wildeman RA; Johnston M; Johnson AL; Gent M
    Br J Clin Pharmacol; 1982 Oct; 14(4):529-37. PubMed ID: 6753888
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of disopyramide and aprindine on arrhythmias after acute myocardial infarction.
    Pouleur H; Chaudron JM; Reyns P
    Eur J Cardiol; 1977 Jul; 5(5):397-404. PubMed ID: 330168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic disopysramide: its clinical effects related to plasma concentration in myocardial infarction.
    Hillson RM; Boyd E; Cunningham J
    J Int Med Res; 1980; 8(5):314-20. PubMed ID: 6998791
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of disopyramide after myocardial infarction.
    Jones MB
    Bristol Med Chir J; 1976; 91(339-340):12. PubMed ID: 802388
    [No Abstract]   [Full Text] [Related]  

  • 5. Disopyramide in the treatment and prevention of arrhythmias following myocardial infarction.
    Zainal N; Jennings G; Jones B; Model D; Turner P; Besterman EM; Kidner PH
    J Int Med Res; 1976; 4(1 Suppl):71-3. PubMed ID: 799982
    [No Abstract]   [Full Text] [Related]  

  • 6. A placebo-controlled study to determine the efficacy of oral disopyramide phosphate for the prophylaxis of ventricular dysrhythmias after acute myocardial infarction.
    Kumana CR; Rambihar VS; Tanser PH; Cairns JA; Gupta RN; Wildeman RA; Johnston M; Johnson AL; Gent M
    Br J Clin Pharmacol; 1982 Oct; 14(4):519-27. PubMed ID: 6753887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disopyramide in myocardial infarction.
    Lancet; 1977 Dec; 2(8049):1185-6. PubMed ID: 73103
    [No Abstract]   [Full Text] [Related]  

  • 8. Oral disopyramide in prophylaxis of arrhythmias following myocardial infarction.
    Jennings G; Jones MS; Besterman EM; Model DG; Turner PP; Kidner PH
    Lancet; 1976 Jan; 1(7950):51-4. PubMed ID: 54578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral disopyramide for the prevention of arrhythmias in patients with acute myocardial infarction admitted to open wards.
    Zainal N; Carmichael DJ; Griffiths JW; Besterman EM; Kidner PH; Gillham AD; Summers GD
    Lancet; 1977 Oct; 2(8044):887-9. PubMed ID: 72237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoprophylaxis of arrhythmias with oral disopyramide in acute myocardial infarction.
    Nigam P; Khan S; Singh R; Kapoor KK; Kumar A; Gupta AK
    J Assoc Physicians India; 1983 Dec; 31(12):759-62. PubMed ID: 6370949
    [No Abstract]   [Full Text] [Related]  

  • 11. Disopyramide in myocardial infarction.
    Kidner PH; Besterman EM
    Lancet; 1978 Mar; 1(8063):562. PubMed ID: 76109
    [No Abstract]   [Full Text] [Related]  

  • 12. Arrhythmia prevention in early myocardial infarction.
    Ward JW
    Lancet; 1977 May; 1(8019):1006. PubMed ID: 67440
    [No Abstract]   [Full Text] [Related]  

  • 13. Randomised placebo-controlled trial comparing oxprenolol with disopyramide phosphate in immediate treatment of suspected myocardial infarction.
    Wilcox RG; Rowley JM; Hampton JR; Mitchell JR; Roland JM; Banks DC
    Lancet; 1980 Oct; 2(8198):765-9. PubMed ID: 6107452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous and oral disopyramide after myocardial infarction.
    Nicholls DP; Haybyrne T; Barnes PC
    Lancet; 1980 Nov; 2(8201):936-8. PubMed ID: 6107587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Disopyramide and lignocaine in the treatment of ventricular arrhythmia in patients with acute ischemic heart disease].
    Pedersen-Bjergaard O; Lindeneg O; Svendsen TL; Enk B; Fridberg M
    Ugeskr Laeger; 1986 May; 148(22):1349-51. PubMed ID: 3523916
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute intervention studies in patients with myocardial infarction using atenolol, propranolol, oxprenolol and disopyramide phosphate.
    Wilcox RG
    Acta Med Scand Suppl; 1981; 651():193-202. PubMed ID: 6119875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, double-blind, parallel group comparison of disopyramide phosphate and quinidine in patients with cardiac arrhythmias.
    Arif M; Laidlaw JC; Oshrain C; Willis PW; Nissen CH; McDermott DJ; Smith WS; Karim A; Wilson RR
    Angiology; 1983 Jun; 34(6):393-400. PubMed ID: 6408949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disopyramide.
    Koch-Weser J
    N Engl J Med; 1979 Apr; 300(17):957-62. PubMed ID: 431563
    [No Abstract]   [Full Text] [Related]  

  • 19. [Preventive disopyramide in patients with ventricular arrhythmias detected by exercise].
    Cardonne A; Pérez-Medina T; García-Barreto D
    Arch Inst Cardiol Mex; 1976; 46(1):69-73. PubMed ID: 779692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disopyramide: a review of its pharmacological properties and therapeutic use in treating cardiac arrhythmias.
    Heel RC; Brogden RN; Speight TM; Avery GS
    Drugs; 1978 May; 15(5):331-68. PubMed ID: 350555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.